Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 65Myelodysplastic Syndromes 64Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma 41Leukemia, Lymphocytic, Chronic, B-Cell 40Multiple Myeloma 35Hodgkin Disease 35Lymphoma, Non-Hodgkin 34Leukemia, Myeloid, Chronic-Phase 34Myeloproliferative Disorders 33Leukemia, Myeloid, Accelerated Phase 31Lymphoma, Follicular 28Lymphoma, B-Cell, Marginal Zone 28Congenital Abnormalities 28Burkitt Lymphoma 28Lymphoma, Mantle-Cell 27Lymphoma, Large B-Cell, Diffuse 27Neoplasms, Plasma Cell 23Lymphoma, Large-Cell, Immunoblastic 23Anemia, Refractory, with Excess of Blasts 23Blast Crisis 22Myelodysplastic-Myeloproliferative Diseases 19Leukemia, Myelomonocytic, Chronic 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Graft vs Host Disease 19Dendritic Cell Sarcoma, Interdigitating 19Primary Myelofibrosis 17Waldenstrom Macroglobulinemia 14Recurrence 14

Interventions

Cytarabine 9fludarabine 5Imatinib Mesylate 5thymoglobulin 3fludarabine phosphate 3Tacrolimus 3Sirolimus 3Methotrexate 3Cyclophosphamide 3Busulfan 3Azacitidine 3zosuquidar trihydrochloride 2venetoclax 2ponatinib 2nilotinib 2enasidenib 2bosutinib 2RO6839921 2Mycophenolic Acid 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Behavior Therapy 2Antilymphocyte Serum 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2spartalizumab 1sabatolimab 1quizartinib 1plerixafor 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid × Antilymphocyte Serum × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

NCT00133367 2016-07-25

Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

Massachusetts General Hospital

Phase 2 Completed
32 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡